🩸 @bioivt Donor demographics aren't the full picture. Learn how immune phenotype, HLA diversity & KIR genetics drive variability and reproducibility in cell therapy & immunology workflows.
📅 Oct 29 | 8 AM PT / 11 AM ET
👉 Register:
buff.ly/TUBOHeU
Replying to @RevvityLifeSci
@revvitylifesci Free CE credits available! Join experts exploring the Lab-in-the-Loop approach, grounding AI-enabled drug discovery predictions in real biological validation.
📅 Nov 11 | 8 AM PT / 11 AM EST
👉 Register:
buff.ly/S6cich6
🌍 Now available on-demand: Explore the Translational Infectious Disease Research Summit and hear from global experts covering vaccine response, immune profiling, pathogen surveillance & more.
Watch now: buff.ly/AVGnMah
IFN1 activation is normally a cellular antiviral response.
In myotonic dystrophy, the trigger may be the cell’s own faulty mRNA, according to a small cell study pointing to a possible drug target. 🧫 💪
buff.ly/EgcrhVh
🌍 Share your science with our global community at Labroots’ 2026 Clinical Diagnostics & Research Virtual Event Series on November 10, 2026. Submit your poster and gain global visibility!
⏰ Deadline: November 6 at 5:00 pm PT
👉 Submit for free: buff.ly/nbaikEL
A study of 12,151 stool samples from 887 children found 3 distinct ways the infant gut microbiome develops. 🦠 👶
One of the three carried a threefold higher risk of type 1 diabetes. 🦧
buff.ly/XTvd5kv
🧬 How can transcriptomic data refine molecular interpretation in cancer testing?
Join the Oct 15 webinar from @SOPHiAGENETICS: “Using transcriptomic data to refine molecular interpretation in laboratory cancer testing”
Register: buff.ly/cldyXUW
#PrecisionMedicine
🫀 @thermofisher From engineered heart tissue to NK cell therapies, see how human-relevant cell models are bridging the path from cells to future therapies.
📅 Oct 29 | 10 AM GMT / 11 AM CET
👉 Register:
buff.ly/dGpbivL
🔬 Join us on November 10 for Labroots’ free Clinical Diagnostics & Research Virtual Event Series 2026!
Explore advances in diagnostic testing, translational research, epidemiology, and clinical laboratory science.
Register now: buff.ly/DyzfNCi
Trusted for over 20 years and cited in 11,000+ publications, FUJIFILM Biosciences' anti-Iba1 antibody delivers reproducible, publication-ready microglia imaging. Order now for consistent, reliable staining.
Learn more: buff.ly/oN9gTyL